Keyword: Bharat Biotech

GSK sells Indian vaccine subsidiary to Bharat; Dr. Reddy's rides a turbulent week; Sandoz sells more U.S. generics.

After the buy, Bharat Biotech will be able to make 25 million doses of rabies vaccine each year, its chairman said.

The FDA fast-tracked Valneva's shot against chikungunya, a disease with no approved vaccines.

PaxVax picked up the FDA's fast track tag for its chikungunya vaccine.

Here's some other vaccine news of note for the week.

Mylan and Biocon win CHMP nod for a Lantus biosimilar, Takeda's Zika vaccine fast-tracked by the FDA, Celltrion got a warning letter.

Ready to challenge GlaxoSmithKline and Merck, India's Bharat Biotech has won WHO prequalification for its rotavirus vaccine Rotavac.

Here is some other vaccine news of note for the week.

Dr. Reddy's recalls more meds in the U.S., while the EMA recanted its plant's GMP certificate; China approved a domestic Ebola vaccine.

No currently available vaccines against typhoid are meant for children younger than 2, but a new WHO endorsement could change that.